Aytu BioPharma Inc. (AYTU)
1.63
0.01 (0.62%)
At close: Jan 15, 2025, 11:13 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
| Net Income | -15.84M | -17.05M | -110.17M | -58.29M | -13.62M | -27.13M | -10.19M | -22.51M | -28.18M | -7.72M | -5.58M | -57.32K | -59.67K | -136.80K | -60.27K | -58.89K | -57.17K | -48.95K |
| Depreciation & Amortization | 8.27M | 8.81M | 10.25M | 9.20M | 6.25M | 2.73M | 2.59M | 4.36M | 874.79K | 118.20K | 97.48K | 4.94K | 6.15K | 6.76K | 9.19K | 8.28K | 7.51K | 6.42K |
| Stock-Based Compensation | 2.91M | 6.05M | 5.25M | 3.57M | 1.08M | 1.02M | 348.51K | 2.50M | 902.95K | 1.02M | 500.00K | 317.00K | n/a | 60.00K | n/a | n/a | n/a | n/a |
| Other Working Capital | -9.37M | 2.58M | -11.01M | 596.00K | -721.90K | 918.13K | -531.61K | -1.38M | 659.02K | -495.84K | -164.19K | -24.00K | 8.34K | 971.00 | 5.13K | -487 | 316.00 | 5.22K |
| Other Non-Cash Items | 7.93M | -404.00K | 76.71M | -4.46M | -10.04M | 9.84M | -6.03M | 1.23M | 403.78K | 121.98K | 35.58K | 8.18K | 7.34K | -132.55K | 2.58K | 4.47K | 4.54K | 9.40K |
| Deferred Income Tax | n/a | 3.26M | n/a | 22.33M | 573.53K | -80.78K | -1.94M | 1.62M | 13.55M | -23.91K | -813.70K | n/a | n/a | 136.80K | n/a | n/a | n/a | n/a |
| Change in Working Capital | -4.66M | -5.80M | -10.86M | 1.68M | -12.61M | -210.20K | -718.81K | -1.04M | 1.79M | -145.02K | 257.68K | 6.49K | 8.34K | 971.00 | 5.13K | -487 | 316.00 | 5.22K |
| Operating Cash Flow | -1.39M | -5.13M | -28.82M | -25.96M | -28.37M | -13.83M | -15.94M | -13.83M | -10.66M | -6.63M | -5.50M | -37.70K | -37.85K | -64.82K | -43.38K | -46.63K | -44.80K | -27.92K |
| Capital Expenditures | n/a | n/a | n/a | -2.34M | n/a | -59.85K | -74.71K | -111.61K | -2.25M | n/a | -9.30K | -8.92K | n/a | n/a | -6.58K | n/a | -7.47K | n/a |
| Acquisitions | n/a | -5.00K | -3.18M | -2.82M | 188.23K | -505.02K | -7.38K | -4.04M | -3.05M | -1.00M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 91.86K | -2.01M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -91.86K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -329.00K | -112.00K | -70.00K | 2.38M | -5.84M | -497.11K | -402.20K | 613.31K | 2.00K | -4.89K | n/a | -330.00K | n/a | n/a | -6.58K | -7.47K | -7.47K | n/a |
| Investing Cash Flow | -329.00K | -117.00K | -3.25M | -2.78M | -5.66M | -1.06M | -484.29K | -3.53M | -5.30M | -1.00M | -9.30K | -338.92K | n/a | n/a | -6.58K | -7.47K | -7.47K | n/a |
| Debt Repayment | -1.89M | -96.00K | -5.22M | -968.00K | -16.25M | 5.00M | n/a | n/a | 5.17M | n/a | 21.48K | 31.46K | 15.75K | 23.77K | 22.98K | 6.50K | 6.80K | 2.40K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -2.84M | -6.61M | -4.94M | -8.87M | 21.59M | 29.26M | 22.66M | 845.19K | -1.23M | 7.35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Financial Cash Flow | -1.26M | 8.87M | 1.53M | 30.31M | 71.07M | 19.08M | 22.66M | 10.19M | 16.66M | 12.35M | 5.24M | 39.46K | 33.97K | 67.27K | 37.88K | 22.60K | 66.55K | 2.40K |
| Net Cash Flow | -2.98M | 3.63M | -30.54M | 1.57M | 37.04M | 4.18M | 6.23M | -7.18M | 701.13K | 4.71M | -274.05K | 1.75K | -3.88K | 2.45K | -12.07K | -24.03K | 14.29K | -25.52K |
| Free Cash Flow | -1.39M | -5.13M | -28.82M | -28.30M | -28.37M | -13.89M | -16.02M | -13.94M | -12.91M | -6.63M | -5.51M | -46.62K | -37.85K | -64.82K | -49.95K | -46.63K | -52.27K | -27.92K |